Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection

NCT03388125 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

113

Enrollment

OTHER

Sponsor class

Conditions

Bleeding Esophageal Varices

Interventions

DRUG: Injection Sclerotherapy
DRUG: N-butyl-2-cyanoacrylate

Sponsor

Sherief Abd-Elsalam